Skip to content

Assessing the effect of the ointment of green tea on the intensity of episiotomy pain and wound healing

Assessing the effect of the ointment of green tea on the intensity of episiotomy pain and wound healing in primiparous women

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016011225983N1
Enrollment
99
Registered
2016-04-01
Start date
2015-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

episiotomy. Second degree perineal laceration during delivery

Interventions

Intervention 1: Green tea ointment is used as much as one knuckle (2cm) on episiotomy wounds twice per day for 10 days. Intervention 2: placebo ointment is used as much as one knuckle (2cm) on epis
Treatment - Drugs
Placebo
Green tea ointment is used as much as one knuckle (2cm) on episiotomy wounds twice per day for 10 days.
placebo ointment is used as much as one knuckle (2cm) on episiotomy wounds twice per day for 10 days.
betadin, 3 times a day for 10 days

Sponsors

Vice Chancellor for research Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: primiparous woman; gestational ages between 37 to 42 weeks; aged 18 to 35 year; BMI between 19.8-30 kg/m2; resident in kerman; was educated; singleton birth with cephalic presentation; child weigh between 2500 to 4000 grams; have a vaginal delivery with mediolateral episiotomy without instrumental delivery and without tears; no rupture of membranes more than 24 hours; not eclampsia and pre-eclampsia; no manual removal of placenta; not taking the first stage of labor (more than 14 hours) and the second stage of labor (more than 2 hours) and the third stage of labor (more than 30 minutes); no fetal anomaly or bedfast to the neonatal unit; have hematoma episiotomy; no addiction; no allergies to topical drugs; the lack of diseases such as chronic systemic disorders, cardiovascular, respiratory, coagulation disorders and connective tissue, diabetes, anemia, immunosuppressant, hemophilia, malnutrition and psychological disorders; no history of injury, or previous surgery of lesions visible in the perineum (genital warts, hemorrhoids), persistent constipation Exclusion criteria: do not visit for care; not interested to continue to participate in the study; do not use the ointment properly and as directed; do not use the betadin properly and as directed; allergic to use ointment; have a sex in the first 5 days after birth; manipulation of the perineum after episiotomy repair; Severe bleeding after childbirth; use drugs on wound healing (anticoagulant, antidepressants, antiepileptic, alcohol, immunosuppressant drugs, antibiotics, chemotherapy) during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intensity of episiotomy pain. Timepoint: before intervention, 12 hours, 5 and 10 days postpartum. Method of measurement: Visual Analogue Scale (VAS).;Wound healing of episiotomy. Timepoint: before intervention, 12 hours, 5 and 10 days postpartum. Method of measurement: REEDA scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadis Shahrahmani

School of Nursing and Midwifery of Shahid Beheshti

hadis.shahrahmani@gmail.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026